Clinical Trials Logo

Filter by:
NCT ID: NCT04804137 Completed - Clinical trials for Metastatic Lung Cancer

Immune Response Under Immunotherapy in Metastatic NSCLC: Sputum, Blood Samples and Microbioata Study

RICEPS
Start date: May 3, 2021
Phase:
Study type: Observational

Prospective pathophysiological exploratory monocentric study, focusing on adult patients with non-small cell lung cancer (NSCLC) : non-squamous type without oncogenic addiction, metastatic, treated with immune checkpoint inhibitors alone or in combination with chemotherapy in front line at the CHRU de Tours, France.

NCT ID: NCT04803786 Completed - Narcolepsy Clinical Trials

A Patient-Centric, Prospective, Observational, Non-Interventional Switch Study of XYWAV in Narcolepsy

Start date: April 9, 2021
Phase:
Study type: Observational

The rationale for the patient-centric, prospective, observational, non-interventional study design of JZP258-402 is to evaluate the transition experience of participants with narcolepsy treated with oxybate and to examine the impact of transitioning from Xyrem to Xywav in a real-world setting.

NCT ID: NCT04803682 Completed - Healthy Subject Clinical Trials

A Smoking Prevention Program (ASPIRE) and Mentoring for Preventing Smoking Among High School Youths

Start date: January 8, 2016
Phase: Early Phase 1
Study type: Interventional

This early phase I trial studies how well A Smoking Prevention Interactive Experience (ASPIRE) program and mentorship works in preventing smoking in high school students. ASPIRE is an online-based, youth-centered tobacco prevention and cessation program. The goal of this research study is to learn if training eleventh grade high school students to be tobacco-free role models and mentors for ninth grade high school students is possible and will positively influence the younger peers.

NCT ID: NCT04803448 Completed - Clinical trials for Patient Lie Detection

Patient Doctor Lies

Start date: February 12, 2020
Phase: N/A
Study type: Interventional

Accurate patient information disclosure is critical to provide optimal treatment. Methods that can detect and then increase the truthfulness of information are relatively unknown. To investigate the impact of communication about privacy, benefits, and risk on patient truthfulness, the investigators test two new methods to detect patient truthfulness and demonstrate the effects of privacy notices (e.g. HIPPA statements). Participants include a national online sample randomly assigned to one of six treatment statements that might be typically given before health information was requested. The assigned treatments include one or mix of the following: privacy notice, statement of the benefits of accurate disclosure, and statement of the risks of inaccurate disclosure and control of no statement before being asked typical health questions. The investigators propose that based on elaboration likelihood model, statements reminding participants of their privacy will increase lying. The investigators hypothesis the use of a new biometric mouse movement lie detection method and answer adjustment can measure patient lies. The investigators hypothesis that reminders of the risk of not telling the truth will reduce lying due to risk aversion. Lastly the investigators hypothesis that statements of benefits of answering truthfully will increase truthfulness.

NCT ID: NCT04803305 Completed - Breast Cancer Clinical Trials

Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia

Start date: May 11, 2021
Phase: Phase 1
Study type: Interventional

Study to compare the effects of the investigational new drug (PF-06946860) and a placebo on appetite and to find out how participants with advanced cancer and anorexia feel after receiving repeated subcutaneous (SC-injected under the skin) doses.

NCT ID: NCT04803045 Completed - Infertility Clinical Trials

Does a Brief Intervention Decrease Patient Drop Out Rates?

Start date: July 1, 2017
Phase:
Study type: Observational

The goal of this study is to determine a) if a follow-up email to selected patients who had an initial consult with an infertility specialist, but did not return for a second visit, would change return to care behavior and b) why patients had not returned.

NCT ID: NCT04802863 Completed - Clinical trials for Bacterial Infections

Intrapulmonary Pharmacokinetics of XNW4107, Imipenem and Cilastatin in Healthy Subjects

Start date: March 25, 2021
Phase: Phase 1
Study type: Interventional

This is a Phase 1, open-label, single-center study of XNW4107 and imipenem/cilastatin administered intravenously.

NCT ID: NCT04802746 Completed - Clinical trials for Healthy Study Participants

A Study to Assess the Pulmonary Safety of Staccato Alprazolam in Healthy Study Participants and in Study Participants With Mild Asthma

Start date: March 9, 2021
Phase: Phase 1
Study type: Interventional

The purpose of the study is to assess the pulmonary safety of Staccato alprazolam in healthy study participants and in and study participants with mild asthma

NCT ID: NCT04802486 Completed - Weight Loss Clinical Trials

The Effects of a 12 Week Home-based Exercise Intervention on Physical Performance in Patients With Cancers of the Gastrointestinal Tract With Pre- Cachexia or Cachexia

Start date: June 29, 2016
Phase: N/A
Study type: Interventional

The main purpose of this research study is to determine if exercise improve or worsen cachexia.

NCT ID: NCT04802460 Completed - Clinical trials for Pain and Hysteroscopy

Virtual Reality Effects on Pain During Hysteroscopy Hysteroscopy: A Randomized Control Trial

VR
Start date: May 1, 2020
Phase: N/A
Study type: Interventional

The Objective of this study is to compare pain levels in women undergoing office-based hysteroscopies using Virtual Reality versus control in a randomized control prospective trial.